AI-generated summary
The authors randomly assigned 95 Chinese patients with severe meibomian gland dysfunction to manual gland expression, intense pulsed light with expression, or LipiFlow and followed them for six months. All three treatments improved symptoms and signs, and intense pulsed light with expression gave the most consistent improvement in symptom scores and tear break-up time. The study did not report a wavelength-based comparison, and the authors note that individualized treatment choice may be important.
- Participants
- 95
- Who or what was studied
- Chinese patients with severe meibomian gland dysfunction
- Limits stated in the abstract
- The abstract does not describe blinding or report effect sizes, and the follow-up period was limited to six months.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Randomized controlled trial. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.